WHIS - Agenda | Kisaco Research
Agenda Days: 
  • Wednesday, 5 Nov, 2025
    Registration
    8:00 AM - 8:55 AM
    Morning Sessions
    • Understand how leaders across sectors are harnessing the opportunity of addressing women’s health
    • Learn where the opportunities are to reap the health and economic returns of closing the gap
    • Get strategic insights on where the health of women market is heading – and how stakeholders can stay ahead
    Innovation and Investment
    Healthcare Costs and Outcomes

    Author:

    Lucy Perez

    Senior Partner, Life Sciences
    McKinsey & Company

    Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

    Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

    Lucy works extensively with number of biopharma and life science clients on broad range of topics, with recent focus on ESG/ sustainability, evidence generation, and digital/analytics programs to improve patient outcomes and support sustainable, inclusive growth.

    Led efforts for a leading biopharma to define their ESG strategy, partnership strategy, and stakeholder engagement approach

    Led efforts for a leading biopharma to embed health equity as a core principle in their R&D priorities and ways of working across the value chain

    Led efforts to assess internal and external portfolio productivity and pricing models to optimize the R&D strategy and redesign the organization for a top pharmaceutical company

    Led efforts for a leading biopharma to transform how it engages with customers through digital transformation, applying advanced analytics and embedding agile ways of working across their six largest markets that delivered $300M+ of near-term growth

    Sponsor of McKinsey’s Early Stage Investor Conference, an annual event convening 200+ entrepreneurs and 1000+ investors interested in bio/med/health tech and sustainability innovation

    Before joining McKinsey, Lucy was a research fellow at Memorial Sloan-Kettering Cancer Center, where she was involved in the development of novel treatments for solid tumors. She was also a Howard Hughes Medical Institute research fellow at Harvard University while completing her doctoral studies. She is co-inventor on multiple patents and has published in peer-reviewed journals.

    Lucy Perez

    Senior Partner, Life Sciences
    McKinsey & Company

    Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

    Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

    Lucy works extensively with number of biopharma and life science clients on broad range of topics, with recent focus on ESG/ sustainability, evidence generation, and digital/analytics programs to improve patient outcomes and support sustainable, inclusive growth.

    Led efforts for a leading biopharma to define their ESG strategy, partnership strategy, and stakeholder engagement approach

    Led efforts for a leading biopharma to embed health equity as a core principle in their R&D priorities and ways of working across the value chain

    Led efforts to assess internal and external portfolio productivity and pricing models to optimize the R&D strategy and redesign the organization for a top pharmaceutical company

    Led efforts for a leading biopharma to transform how it engages with customers through digital transformation, applying advanced analytics and embedding agile ways of working across their six largest markets that delivered $300M+ of near-term growth

    Sponsor of McKinsey’s Early Stage Investor Conference, an annual event convening 200+ entrepreneurs and 1000+ investors interested in bio/med/health tech and sustainability innovation

    Before joining McKinsey, Lucy was a research fellow at Memorial Sloan-Kettering Cancer Center, where she was involved in the development of novel treatments for solid tumors. She was also a Howard Hughes Medical Institute research fellow at Harvard University while completing her doctoral studies. She is co-inventor on multiple patents and has published in peer-reviewed journals.

    • How can companies evidence value to payers in relation to existing solutions and models?
    • As women’s health evolves, what areas are of greatest interest to payers?
    • Exploring women’s health through a value-based care, Medicaid, government, and population health lens.
    Innovation and Investment
    Healthcare Costs and Outcomes

    Author:

    Dianne Balon

    SVP of Government
    Blue Cross Alberta

    Dianne Balon

    SVP of Government
    Blue Cross Alberta

    Author:

    Katie Ryan

    Senior Innovation Strategist
    Humana

    Katie Ryan

    Senior Innovation Strategist
    Humana

    Author:

    Alice Zheng, MD, MBA, MPH

    Principal
    Foreground Capital

    Alice Zheng, MD, MBA, MPH

    Principal
    Foreground Capital
    Networking Break
    10:00 AM - 11:00 AM
    Morning Sessions

    Hear from investors with a range of funds, interests, and rounds available to companies active in healthcare sectors that only, differently, or disproportionately affect women. Tailor your company pitch to meet the needs of these investment experts.

    Innovation and Investment

    Author:

    Anna Valcheva

    Venture Partner
    Alumni Ventures Group

    Anna Valcheva

    Venture Partner
    Alumni Ventures Group

    Author:

    Megan Dover

    Principal and Co- Founder
    Cross-Border Impact Ventures

    Megan Dover

    Principal and Co- Founder
    Cross-Border Impact Ventures
    • Sharing perspectives from leaders in women's health, entrepreneurship, ecosystem building, and investment to explore the creation of thriving FemTech ecosystems.
    • Delving into FemTechAZ's model, dissecting key barriers facing innovation, and outlining practical strategies for building supportive regional networks.
    • Featuring insights from market validation and mission to establish Arizona as a blueprint for developing regional innovation ecosystems.
    Innovation and Investment
    Digital Health

    Author:

    Susan Sly

    Founder & CEO
    The Pause.ai

    Susan Sly is the Co-CEO and cofounder of RadiusAI (RAI), an award-winning visual intelligence company specializing in the retail and healthcare sectors. RAI is currently implementing its smart retail solution at the edge for a national retailer with 1,000 locations.

     

    RAI has been named one of the fastest growing startups in Phoenix three years in a row and won VentureBeat’s AI Innovation at the Edge Award in 2022, beating out several highly acclaimed technology companies.

     

    Prior to cofounding RAI, Susan led channel sales teams in three sectors generating over $2 billion in revenue. In her spare time, Susan is the host of the highly acclaimed podcast, Raw and Real Entrepreneurship, mom of five, wife, and tech investor. Susan has appeared on CNN, CNBC, Fox, ABC Family, and is a member of the prestigious Forbes Business Council.

    Susan Sly

    Founder & CEO
    The Pause.ai

    Susan Sly is the Co-CEO and cofounder of RadiusAI (RAI), an award-winning visual intelligence company specializing in the retail and healthcare sectors. RAI is currently implementing its smart retail solution at the edge for a national retailer with 1,000 locations.

     

    RAI has been named one of the fastest growing startups in Phoenix three years in a row and won VentureBeat’s AI Innovation at the Edge Award in 2022, beating out several highly acclaimed technology companies.

     

    Prior to cofounding RAI, Susan led channel sales teams in three sectors generating over $2 billion in revenue. In her spare time, Susan is the host of the highly acclaimed podcast, Raw and Real Entrepreneurship, mom of five, wife, and tech investor. Susan has appeared on CNN, CNBC, Fox, ABC Family, and is a member of the prestigious Forbes Business Council.

    Author:

    Sidnee Peck

    Co-Founder
    FemtechAZ

    Sidnee Peck

    Co-Founder
    FemtechAZ

    Author:

    Azin Radsan van Alebeek

    Co-Founder & General Partner
    Emmeline Ventures

    Azin Radsan van Alebeek

    Co-Founder & General Partner
    Emmeline Ventures

    Author:

    Mitzi Krockover

    Co-Founder, FemtechAZ
    Managing Director, Golden Seeds, CEO, Woman Centered

    Mitzi Krockover

    Co-Founder, FemtechAZ
    Managing Director, Golden Seeds, CEO, Woman Centered

    Author:

    Scarlett Spring

    Executive Director
    Phoenix Bioscience Core

    Scarlett Spring

    Executive Director
    Phoenix Bioscience Core
    Lunch Break
    12:20 PM - 1:30 PM
    Afternoon Sessions

    From the latest apps, wearables, digital therapeutics and diagnostics, AI and M/L, the Startup Showcase brings you 6 investor selected seed & series A disruptors poised to transform consumer women’s health.

    Join this rapid-fire pitching session to hear from our startup finalists, followed by questions from a judging panel of expert investors. Come along to see the who’s who dominating the startup landscape.

    Innovation and Investment
    • Exploring how advancements in the fertility industry improving success rates translates into greater access.
    • How policy and business models can provide opportunities regardless of geography, income, background, and sexuality.
    Fertility

    Author:

    Dr. Neel Shah

    Chief Medical Officer
    Maven Clinic

    Dr. Neel Shah

    Chief Medical Officer
    Maven Clinic

    Author:

    Lynn Mason

    Chief Executive Officer
    IVI RMA GLOBAL

    Lynn Mason

    Chief Executive Officer
    IVI RMA GLOBAL

    Author:

    Kate Devine

    Chief Research Officer
    USFertility

    Kate Devine

    Chief Research Officer
    USFertility
    • Delving into how policy and insurance coverage is shaping national maternal health standards.
    • Showcasing Kaiser Permanente’s approach to value-based care models, accessibility, and population health.
    • How the ‘cocoon model’ surrounds women with holistic supportive care beyond clinical monitoring during pregnancy.
    Maternal Health
    Healthcare Costs and Outcomes

    From the latest drug developments, diagnostic devices and tools, the Startup Showcase brings you the best of the best innovators disrupting the space.

    Join this rapid-fire pitching session to hear from our 6 seed / series A startup finalists developing the next generation of regulated medical products, followed by questions from a judging panel of expert investors. Come along to see the who’s who dominating the startup landscape.

    Innovation and Investment
    • How fertility companies are expanding into broader women’s health areas like menopause, sexual health, and mental health and the partnership opportunities this creates for more holistic patient care.
    • How addressing reproductive, mental, and metabolic health can translate to fertility success.
    • Patient-centred approaches that leverage collaborations to address unmet needs across a woman's entire lifespan, including reproductive, mental, and cardiovascular health.
    Fertility
    Reproductive Health

    Author:

    Janet Choi

    Chief Medical Officer
    Progyny

    Janet Choi

    Chief Medical Officer
    Progyny
    • How remote monitoring and wearables are improving maternal outcomes through data-backed decision making.
    • Addressing the “fourth trimester” with digital tools and at home care.
    • Investment, commercialization, and coverage strategies for maternal health technology.
    Maternal Health
    Innovation and Investment

    Author:

    Rachel Springate

    Founding Partner
    Muse Capital

    Rachel Springate

    Founding Partner
    Muse Capital
    • Navigating the financial pathways of fertility care, addressing complexities in coverage across the clinical journey.
    • Exploring how leaders are using insurance innovation, employer benefits, fintech tools, and electronic health records to reduce friction, increase cost transparency, and help more patients access the care they need.
    Fertility
    Healthcare Costs and Outcomes

    Author:

    Chloe Cai

    CEO
    New Hope Fertility Center

    Chloe Cai

    CEO
    New Hope Fertility Center

    Author:

    Sheeva Talebian

    Reproductive Endocrinologist
    CCRM New York

    Sheeva Talebian

    Reproductive Endocrinologist
    CCRM New York
    • Uncover the technologies and breakthroughs around behavioural health practices
    • Prescribing behavioural health support strategies are effective for tackling mental health for new mothers.
    • How to maintain good mental, physical, and emotional health across the day-to-day life.
    Maternal Health
    Brain Health

    Author:

    Leslie Forde

    CEO & Founder
    Mom's Hierarchy of Needs

    Leslie Forde

    CEO & Founder
    Mom's Hierarchy of Needs
    Networking Break
    3:30 PM - 4:00 PM
    Afternoon Sessions
    • Sharing consumer insights into how stigma surrounding women’s health influences purchasing and channel engagement.
    • The role of branding and education in normalizing conversations and driving purchasing behavior.
    • How businesses can collaborate to improve trust, and empower women to center their own health needs.
    Consumer Health

    Author:

    Jenny Fisher

    Head of Strategy & Transformation, Adult Feminine Care
    Kimberly Clark

    Jenny Fisher

    Head of Strategy & Transformation, Adult Feminine Care
    Kimberly Clark
    • Sharing personal stories of RPL and miscarriage, what factors play a role and the outcome this has on families.
    • How employers, healthcare providers, and insurers can better support women experiencing miscarriage.
    • Opportunities to tackle miscarriage through mental health resource, education, technology, and partnerships.
    Reproductive Health
    Maternal Health

    Author:

    Cindy Rahman

    President & CEO
    March of Dimes

    Cindy Rahman

    President & CEO
    March of Dimes

    Author:

    Brandi Howard

    SVP of Clinical Affairs
    Conceptra Biosciences

    Brandi Howard

    SVP of Clinical Affairs
    Conceptra Biosciences
    • Examining the growing uptake in menopause treatments that cater specific stages and symptoms of menopause.
    • Ensuring that personalized menopause treatments are accessible to all women, including socio-economic, cultural, and healthcare system barriers.
    • Analyzing trends in provider menopause education & support and payer coverage for holistic menopause care.

     

    Menopause and Longevity

    Author:

    Asima Ahmad

    Chief Medical Officer
    Carrot Fertility

    Asima Ahmad

    Chief Medical Officer
    Carrot Fertility

    Author:

    Claire Gill

    CEO
    Menopause Foundation

    Claire Gill

    CEO
    Menopause Foundation
    • How can we maximise the use of real time data driven by wearables, at-home diagnostics, and digital health platforms across the women’s health ecosystem.
    • Creating business opportunities in leveraging women’s health data for product innovation, personalized care, and strategic partnerships with healthcare and retail.
    Digital Health
    Consumer Health

    Author:

    Dorothy Kilroy

    Chief Commerical Officer
    Oura

    Dorothy Kilroy

    Chief Commerical Officer
    Oura

    Author:

    Florence Comite

    CEO & Founder
    Comite Center for Longevity

    Florence Comite

    CEO & Founder
    Comite Center for Longevity

    Author:

    Rhiannon White

    CEO
    Clue

    Rhiannon White

    CEO
    Clue

    Author:

    Sylvia Kang

    CEO
    Miracare

    Sylvia Kang

    CEO
    Miracare
    • Sharing how the telehealth industry is evolving to cater the needs of women across states and regions in the US.
    • Discussing how virtual care supports patient access in stigmatised health conditions and abortion care.
    • Where and when telehealth is the optimal means of engagement in women’s health and how telehealth companies can tailor to the needs of women.
    Reproductive Health
    Digital Health

    Author:

    Jenny Sheehan

    Director of Telehealth & Access Support
    National Abortion Foundation

    Jenny Sheehan

    Director of Telehealth & Access Support
    National Abortion Foundation

    Author:

    Angel Foster

    Co-Founder
    The Massachusetts Medication Abortion Access Project (The MAP)

    Dr. Angel M. Foster is a Professor in the Faculty of Health Sciences at the University of Ottawa and the 2024-2029 University Research Chair in Medication Abortion Studies. A 1996 Rhodes Scholar, she holds a doctorate from the University of Oxford, an MD from Harvard Medical School, and both master’s and bachelor’s degrees from Stanford University. Dr. Foster is a global abortion researcher and leads projects in 22 countries. She has authored more than 150 articles, co-edited three books, and serves as the Editor-in-Chief of Perspectives on Sexual and Reproductive Health. She received the Guttmacher Institute’s 2017 Darroch Award for Excellence in Sexual and Reproductive Health Research and was inducted into the Canadian Academy of Health Sciences in 2023.

    Angel Foster

    Co-Founder
    The Massachusetts Medication Abortion Access Project (The MAP)

    Dr. Angel M. Foster is a Professor in the Faculty of Health Sciences at the University of Ottawa and the 2024-2029 University Research Chair in Medication Abortion Studies. A 1996 Rhodes Scholar, she holds a doctorate from the University of Oxford, an MD from Harvard Medical School, and both master’s and bachelor’s degrees from Stanford University. Dr. Foster is a global abortion researcher and leads projects in 22 countries. She has authored more than 150 articles, co-edited three books, and serves as the Editor-in-Chief of Perspectives on Sexual and Reproductive Health. She received the Guttmacher Institute’s 2017 Darroch Award for Excellence in Sexual and Reproductive Health Research and was inducted into the Canadian Academy of Health Sciences in 2023.

    Author:

    Yenee Bekele

    Medical Director
    Feminist Center for Reproductive Justice

    Yenee Bekele

    Medical Director
    Feminist Center for Reproductive Justice

    Author:

    Ushma Upadhyay

    Professor
    UCSF

    Ushma Upadhyay

    Professor
    UCSF
    • Shed light on Mayo Clinics’ expansion into longevity medicine and the benefits this field has for women.
    • Discussing the role of AI and pharmaco-genetics, and how this is weighed against food as medicine, mental health, and wellness plans.
    • How diagnosis influences lifestyle medicine from pre-conception to menopause and across a women’s reproductive health journey.
    Fertility
    Menopause and Longevity

    Author:

    Adrijana Kekic

    Associate Director, Experiential Education Pharmacy
    Mayo Clinic

    Adrijana Kekic

    Associate Director, Experiential Education Pharmacy
    Mayo Clinic

    Author:

    Rashmi Kudesia

    Reproductive Endocrinologist
    CCRM Houston

    Rashmi Kudesia

    Reproductive Endocrinologist
    CCRM Houston
    • Sharing examples of partnerships between technologies enabling scalable and sustainable femtech solutions across fertility, menopause, and maternal health.
    • Learn how infrastructure & software services are bridging data, clinical care, and benefits to power integrated women's health ecosystems.
    • Hear from leaders building the digital backbone that supports innovation, provider partnerships, and better patient outcomes through patient monitoring & engagement
    Digital Health
    Consumer Health

    Author:

    Tamara Orlova

    CFO
    Flo Health

    Tamara Orlova

    CFO
    Flo Health
    • Integrating advanced MRI and ultrasound to enable surgical pre-staging and personalized planning.
    • Expanding access to robotic-assisted excision surgery to address the shortage of trained surgeons and technologies.
    • Bridging clinical innovation and business investment to scale precision care models.
    Reproductive Health
    • How the demand for menopause-focused functional foods, probiotics, and supplements is shaping new business opportunities.
    • Sharing insights into how nutrition and food as medicine links bone, heart, and brain health in menopause and the opportunity to address these health outcomes through wellness.
    • Expanding access to menopause nutrition solutions through pharmacies, e-commerce, consumer wellness, and employer plans.
    Menopause and Longevity
    Nutrition and Food as Medicine

    Author:

    Jacqueline Oliveira-Cella

    Founder
    wellBe Consulting

    Jacqueline Oliveira-Cella

    Founder
    wellBe Consulting

    Author:

    Laura Katz

    CEO
    Helaina

    Laura Katz

    CEO
    Helaina
    Networking Drinks Reception
    5:30 PM
  • Thursday, 6 Nov, 2025
    Registration
    8:00 AM - 8:55 AM
    Morning Sessions
    • Understanding FDA approval pathways for women's health drugs and devices.
    • Addressing regulatory gaps and challenges in clinical trial design and data collection.
    • Strategies for working with regulators to accelerate innovation and ensure patient safety.
    Drug Development
    Med Device
    • Addressing the under-representation of women in cardiovascular studies and how data-driven clinical outcomes are essential for tailored treatments.
    • How new technologies, screenings, and wearables are improving early detection and prevention of heart disease in women.
    • How partnerships between healthcare providers, pharmaceutical companies, device, and tech companies, can drive better cardiovascular outcomes for women.
    Cardiovascular Health

    Author:

    Tracy Warren

    Senior Managing Director, Go Red for Women Fund
    American Heart Association

    Tracy Warren

    Senior Managing Director, Go Red for Women Fund
    American Heart Association

    Author:

    Nisha Parikh

    System Director, Women’s Heart Program
    Northwell Health

    Nisha Parikh

    System Director, Women’s Heart Program
    Northwell Health
    Networking Break
    10:00 AM - 11:00 AM
    Morning Sessions
    • Discussing the financial burden associated with contraception, gaps in coverage, and how this influences retail access.
    • Sharing commercial opportunities by making low-cost contraception more available through ecosystem partnerships.
    • How can the industry operationalize OTC coverage and distribution of contraception and other women’s health medications.
    Consumer Health
    Healthcare Costs and Outcomes

    Author:

    Victoria Nichols

    Senior Project Director, Free the Pill
    Ibis Reproductive Health

    Victoria Nichols

    Senior Project Director, Free the Pill
    Ibis Reproductive Health

    Author:

    Flavia Mason

    Global Vice President, Women's Health
    Perrigo

    Flavia Mason

    Global Vice President, Women's Health
    Perrigo
    • Exploring how housing, nutrition, identity, and income shape maternal outcomes.
    • Highlighting programs and solutions that integrate social support with clinical care.
    • Discussing actionable strategies in the clinical setting that embed accessibility and education into maternal health systems.
    Nutrition and Food as Medicine
    Maternal Health

    Author:

    Nawal Nour

    Chair & Director of Obstetrics & Gynecology
    Brigham and Women’s Hospital

    Nawal Nour

    Chair & Director of Obstetrics & Gynecology
    Brigham and Women’s Hospital
    • How to mitigate inappropriate drug use and dosing risk, leveraging mechanisms like Pre-Approval Information Exchange (PIE) and PDUFA timelines to shape understanding of indication, value, and safety.
    • How to engage payers as early as phase 2 to build trust and tailor future value-based contracts, launching with outcomes-driven frameworks to support access and reimbursement.
    Healthcare Outcomes
    Innovation and Investment

    Author:

    Jim Kenney

    Founder – JTKENNEY
    Former Manager, Specialty and Pharmacy Contracts - Harvard Pilgrim Health Care

    Jim Kenney

    Founder – JTKENNEY
    Former Manager, Specialty and Pharmacy Contracts - Harvard Pilgrim Health Care
    • Discussing the emerging trends of women’s health education & awareness on social media.
    • How companies can best utilize social media for marketing & business opportunity.
    • Addressing misinformation, trust and health literacy impacting health & wellness decision-making.
    Reproductive Health
    Fertility
    Digital Health

    Author:

    Roohi Jeelani

    Chief Growth Officer
    Kindbody

    Roohi Jeelani

    Chief Growth Officer
    Kindbody
    • Leveraging tech and epidemiological data to reduce diagnostic delays in reproductive health.
    • Exploring AI, biomarkers, digital therapeutics, and digital platforms that enable earlier and more accurate diagnoses.
    • Advice to start-ups and sharing the market opportunity for clinical integration in preventative & diagnostic women’s health.
    Reproductive Health
    Digital Health

    Author:

    Miller Morris

    CEO
    Comma

    Miller Morris

    CEO
    Comma
    • How payers can apply AI and predictive analytics to optimize cost structures in women’s healthcare.
    • The role of structured and unstructured data in improving patient outcomes and reducing financial barriers.
    • Actionable insights for startups: what data to prioritize and how to maximize its value when working with payers and providers.

     

    Healthcare Costs and Outcomes
    Innovation and Investment

    Author:

    Angela Rastegar

    CEO
    Sunfish

    Angela Rastegar

    CEO
    Sunfish
    • Concrete guidance on accessing non-dilutive and dilutive funding - what’s available, what’s working, and how to get it.
    • Strategies for founders and funders to navigate uncertainty and build investable, scalable ventures in women's health.
    • How women, as both innovators and investors, are transforming the funding ecosystem - and how to leverage that shift now.
    Digital Health
    Innovation and Investment

    Author:

    Lisa Marceau

    CEO
    Joyuus

    Lisa Marceau

    CEO
    Joyuus
    • Elucidating how researchers are using menstrual effluent to track fertility, inflammation, and disease.
    • Consumer Adoption & Clinical Validation – The path to making menstrual-based diagnostics a mainstream health tool.
    • Investment & Industry Growth – The market potential of menstrual-based biomarkers in diagnostics and therapeutics.
    Reproductive Health

    Author:

    Lara Zibners

    Co-Founder
    Calla Lily Clinical Care

    Lara Zibners

    Co-Founder
    Calla Lily Clinical Care
    • How employers are integrating fertility, menopause, and maternal health into employee health plans.
    • Addressing workplace challenges like menstrual health, caregiving, and chronic conditions.
    • The ROI of Women's Health Investment – How employer-driven health initiatives improve retention.
    Brain Health
    Nutrition and Food as Medicine
    Healthcare Costs and Outcomes

    Author:

    Maxine Carrington

    Chief People Officer
    Northwell Health

    Maxine Carrington

    Chief People Officer
    Northwell Health
    Lunch Break
    12:30 PM - 1:30 PM
    Afternoon Sessions
    • Demystifying product-market fit in the context of digital health, where clinical need, usability, and reimbursement must align.
    • Identifying key indicators—user adoption, engagement, and outcomes—that show readiness to scale.
    • Strategies for translating validated need into scalable, sustainable digital health solutions.
    Innovation and Investment
    • Expanding access to mammograms and diagnostics in underserved communities.
    • Personalizing Risk Assessment & Early Detection, how AI, genetic testing, and targeted outreach are improving outcomes.
    • The adoption of innovation in breast & cervical cancer screening centred around patient centricity.
    Oncology
    Digital Health
    • Sharing new clinical outcomes and how clinical trials are evolving.
    • Exploring the link between menopause, estrogen, and cognitive decline.
    • How biomarkers, digital tools, and lifestyle interventions can improve outcomes.
    Brain Health
    • Explore how biomarker-driven approaches are streamlining trial design, improving patient stratification, and accelerating time-to-approval for women’s health therapeutics.
    • Learn how collaborations between industry, academia, biotech, and pharma are turning early-stage biomarker insights into clinically actionable endpoints.
    • How to maximise the use of biobanks in biomarker discovery.

    Author:

    Sanj Singh

    CEO
    Temple Therapeutics

    Sanj Singh

    CEO
    Temple Therapeutics
    • Discuss strategies for trial design that account for hormonal fluctuations, comorbidities, and age-related variables unique to the menopausal transition.
    • Highlight regulatory, industry, and advocacy efforts that are pushing for menopause-specific representation in therapeutic areas beyond just women’s health.
    • Sharing advancements to educate clinical trial patients about menopause.
    Menopause and Longevity
    Drug Development
    Afternoon Sessions
    • Learn how to align clinical development strategies with licensing milestones to accelerate commercialization in women’s health.
    • Explore what pharma and late stage investors look for in licensing-ready assets, from early efficacy signals to regulatory preparedness.
    • Understand how to navigate clinical, legal, and market access challenges unique to women’s health to build a compelling licensing case.
    Drug Development

    Author:

    Oliver Bates

    Chief Executive Officer
    Viramal

    Oliver Bates

    Chief Executive Officer
    Viramal
    • Explore the mechanism of action and preclinical efficacy of a first-in-class oncolytic peptide targeting triple negative breast cancer (TNBC).
    • Understand how peptide-based approaches offer new hope for aggressive and treatment-refractory subtypes of breast cancer.
    • Learn about the breast cancer therapeutic roadmap and landscape.
    Oncology
    Drug Development

    Author:

    Mark Eccleston

    Chief Executive Officer
    ValiRx

    Mark Eccleston

    Chief Executive Officer
    ValiRx
    • Discover how real-world data, genomics, and AI are revealing new targets and mechanisms in female-specific and reproductive conditions.
    • Learn how data integration is shortening timelines from target identification to preclinical validation.
    • Sharing insights into novel drug discovery approaches, the use of AI, multi-omics data, and 3D models.
    Reproductive Health
    Drug Development

    Author:

    Stasa Stankovic

    Chief Executive Officer
    Ovartix

    Stasa Stankovic

    Chief Executive Officer
    Ovartix
    • Sharing the role of technology and partnerships in the design & recruitment of studies.
    • Highlighting adaptive trial designs, decentralized models, and inclusive recruitment strategies.
    • Exploring how smarter trial design accelerates approval, reduces risk, and improves real-world outcomes.
    End of WHIS 2025
Agenda Tracks: 
Track Title: 
Innovation & Start-Up Breakthroughs
Track Color: 
#0282ff
Track Title: 
Fertility Insights
Track Color: 
#f532ed
Track Title: 
Maternal Health
Track Color: 
#af13ff
Track Title: 
Consumer & Digital Health
Track Color: 
#42d6fa
Track Title: 
Reproductive Health
Track Color: 
#915ee8
Track Title: 
Menopause & Longevity
Track Color: 
#ff4b56
Track Title: 
Drug & Device Development
Track Color: 
#915ee8
Track Title: 
Across the Healthspan
Track Color: 
#ff4b56